2.2.2. Biochemical Analysis Study 2

There were no significant differences detected between the four groups for any of the lipid measures, blood pressure and glucose, both fasting glucose, and two-hour response to the OGTT (Table 6).

**Table 6.** Lipid and glucose baseline, post (6 or 12 weeks) and change data after placebo or SXRG84 treatment (Study 2). Data are presented as median (25th and 75th percentile). AA = Placebo for 6 weeks; AB = Placebo for 6 weeks then SXRG treatment for 6 weeks; BB = SXRG treatment for 6 weeks; BA = SXRG treatment for 6 weeks then placebo for 6 weeks.


Change determined by median post value (6 or 12 weeks) minus median baseline value. \* *p*-value at baseline determined by *T*-test on normal, log-transformed (§), or Wilcoxon signed rank test (¥) between the two baseline regime groups. *p*-value for post measure determined by ANCOVA using absolute data from 6 weeks (for placebo and active group) and 12 weeks (for placebo then active group and active then placebo group) using baseline data as a covariate.
